The pogress at European Association of Urology (EAU)
EAU2023 has come to an end. Scientific sessions demonstrated the constant and solid progress EchoLaser is making as a game changer for the treatment of BPH:
- The first randomized clinical trial vs TURP shows that 96% of the patients treated with EchoLaser were able to preserve ejaculation.
- The first comparative analysis EchoLaser vs Rezum (Boston Scientific) shows that not going through the urethra makes a significant impact on patients suffering from Benign Prostatic Hyperplasia who seek the optimal treatment.
- Although there are many treatment options for patients suffering from Benign Prostatic Hyperplasia, none has proven to be optimal so far and bears risks for patients. Such risks are minimized by EchoLaser.Which was proven to be safe, efficacious and results are stable over time (3 years).
Patients suffering from Benign Prostatic Hyperplasia have now a new treatment modality to discuss with their urologist: EchoLaser, CE marked and FDA cleared
Thermoablation for Benign Thyroid Nodules
EchoLaser ModìLite arrives on the big screen: a #microinvasive treatment for the treatment of thyroid nodules.
Doctor Fedele Antonio De Marino explains with great simplicity a safe and fast thermoablation procedure.
Listen to his interview:
Excellent surgery, at the Villa Azzurra Nursing Home
“…. Medicine is a field in which every innovation involves improvements for the whole human race, so every opportunity to update their knowledge can only be an investment for the common well-being and for their personal growth. “
The EchoLaser SoracteLite TPLA treatment begins at the Casa di Cura Villa Azzurra. A unique success that will help many people:
EchoLaser SoracteLite TPLA: now on RAI national TV
TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology.
Prof. Bove was one of the first users of EchoLaser and is the principal investigator of the first randomized clinical trial on this application: enrollment was closed and its publication is expected to be out in 2023.
https://www.raiplay.it/video/2022/10/734-Echolaser-per-lipetrofia-prostatica-b6f85178-0c69-403e-aa43-ac8703496600.html